반응식
[F:1][C:2]1[CH:3]=[C:4]([C:12]2[O:16][N:15]=[C:14]([C:17]3[CH:18]=[CH:19][C:20]([CH2:23][N:24]4[CH2:27][CH:26]([C:28]([O:30]C)=[O:29])[CH2:25]4)=[N:21][CH:22]=3)[N:13]=2)[CH:5]=[CH:6][C:7]=1[CH2:8][CH:9]([CH3:11])[CH3:10].[OH-].[Na+]>>[F:1][C:2]1[CH:3]=[C:4]([C:12]2[O:16][N:15]=[C:14]([C:17]3[CH:18]=[CH:19][C:20]([CH2:23][N:24]4[CH2:25][CH:26]([C:28]([OH:30])=[O:29])[CH2:27]4)=[N:21][CH:22]=3)[N:13]=2)[CH:5]=[CH:6][C:7]=1[CH2:8][CH:9]([CH3:10])[CH3:11]참가 물질
3
실험 절차
The title compound (90 mg) was synthesized in a yield of 81% as a white crystalline solid using methyl 1-({5-[5-(3-fluoro-4-isobutylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-yl}methyl)azetidine-3-carboxylate (0.12 g, 0.27 mmol) that was obtained in Example 23 (23g) and a 1 N aqueous solution of sodium hydroxide (0.81 mL, 0.81 mmol) by conducting the reaction similar to that mentioned in Example 3 (3e).
후처리
- customthe reaction similar to
출처 및 근거
- ORD 기록
- ord-26fdd7c863c74dbe8014ded4f1fd3d0a
- 출처 데이터셋
- uspto-grants-2010_03
- 특허 번호
- US07687491B2
연결된 노트
불러오는 중…